2018
DOI: 10.1080/08820139.2018.1538236
|View full text |Cite
|
Sign up to set email alerts
|

Characterization of Natural Killer Cells in HIV Patients Beginning Therapy with a High Burden of Cytomegalovirus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
9
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6

Relationship

3
3

Authors

Journals

citations
Cited by 8 publications
(15 citation statements)
references
References 21 publications
1
9
0
Order By: Relevance
“…Levels of antibody reactive with CMV lysate increased on ART and were markedly higher than in healthy controls. These findings match those reported with the original JakCCANDO cohort (n = 82) [ 14 , 17 ]. As 52% of the original JakCCANDO cohort were CMV DNA+ at V0, we selected 20 HIV patients with and 20 without CMV DNA for this study.…”
Section: Resultssupporting
confidence: 90%
See 2 more Smart Citations
“…Levels of antibody reactive with CMV lysate increased on ART and were markedly higher than in healthy controls. These findings match those reported with the original JakCCANDO cohort (n = 82) [ 14 , 17 ]. As 52% of the original JakCCANDO cohort were CMV DNA+ at V0, we selected 20 HIV patients with and 20 without CMV DNA for this study.…”
Section: Resultssupporting
confidence: 90%
“…Levels of CMV-reactive antibodies were determined relative to a standard plasma pool assigned a value of 1000 arbitrary units (AU). The protocol provides accurate quantitation in the high range [ 17 ]. CMV DNA was detected in buffy coats by qPCR using primer and probe sequences targeting the UL54 gene as described previously [ 14 ].…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…The high proportion of patients beginning ART with detectable CMV DNA is pertinent to this. 18 Earlier studies 9,15,17 suggest complicated associations between RAC, inflammation and markers of lipid metabolism. Further investigations into the apparently protective role of CMV appear to be warranted, and should address both eyes as the underlying mechanisms may be different.…”
Section: Discussionmentioning
confidence: 98%
“…Its expression in HIV patients is increased by their burden of CMV and reduced by a deletion mutation, with complex patterns seen in heterozygotes. 18 Here we address variations in genes encoding inflammatory mediators and NK receptors, and assess which can affect RAC in each eye in HIV patients beginning ART. We align the data with the effects of genotype on CD4 T-cell counts and control of HIV replication.…”
Section: Introductionmentioning
confidence: 99%